Altered expression of microRNA-30a-3p in papillary thyroid cancer and its association with clinicopathological characteristics
Autor: | Ivan Paunovic, Vladan Živaljević, Vesna Mandusic, Boban Stanojevic, Biljana Vucetic Tadic, Lidija Todorović |
---|---|
Rok vydání: | 2020 |
Předmět: |
0301 basic medicine
Capsular Invasion endocrine system diseases advanced stage General Biochemistry Genetics and Molecular Biology Papillary thyroid cancer 03 medical and health sciences 0302 clinical medicine expression microRNA thyroid cancer Medicine Clinical significance Stage (cooking) lcsh:QH301-705.5 Thyroid cancer papillary thyroid cancer (ptc) business.industry miR-30a-3p Thyroid Cancer medicine.disease mir-30a-3p papillary thyroid cancer (PTC) 3. Good health 030104 developmental biology medicine.anatomical_structure lcsh:Biology (General) 030220 oncology & carcinogenesis Cancer research General Agricultural and Biological Sciences business |
Zdroj: | Archives of Biological Sciences, Vol 72, Iss 1, Pp 31-36 (2020) Archives of Biological Sciences |
ISSN: | 1821-4339 0354-4664 |
DOI: | 10.2298/abs191004063t |
Popis: | Paper description: Identification of novel molecular biomarkers can aid in stratification of patients with papillary thyroid cancer (PTC) into low- and high-risk prognostic groups. A growing body of evidence suggests a role for microRNA-30a-3p in aggressiveness and progression of various types of cancer. We show that miR-30a-3p expression levels were deregulated in PTC compared to non-tumor thyroid tissues. Decreased expression was associated with advanced stage, multifocality and capsular invasion. This is one of few studies of microRNA-30a-3p expression in PTC, indicating its potential involvement in the development and/or progression of this type of cancer. Abstract: A growing number of studies suggest a tumor suppressive role and potential prognostic significance of miR-30a-3p in different types of cancer. However, relatively few studies have focused on this microRNA in neoplastic thyroid lesions, including papillary thyroid cancer (PTC). The aim of our study was to shed more light on the potential involvement and clinical relevance of miR-30a-3p in this type of cancer. We examined the expression levels of this microRNA in 42 pairs of PTCs and matched non-tumor thyroid tissues using quantitative RT-PCR. We analyzed their association with clinical and histopathological parameters. The results revealed that miR-30a-3p was significantly downregulated in the majority of PTC tissues compared to corresponding non-tumor tissues. Moreover, decreased expression of miR-30a-3p was associated with advanced clinical stage, presence of multiple tumor foci and capsular invasion, suggesting a role in aggressive disease. Although the role of this microRNA and its prognostic utility remain to be elucidated, the presented data suggest that downregulated expression of miR-30a-3p indicates poorer prognosis in PTC patients, warranting further investigations. https://doi.org/10.2298/ABS191004063T Received: October 4, 2019; Revised: October 14, 2019; Accepted: October 15, 2019; Published online: October 25, 2019 How to cite this article: Todorovic L, Mandusic V, Vucetic Tadic B, Živaljevic V, Paunovic I, Stanojevic B.Altered expression of microRNA-30a-3p in papillary thyroid cancer and its association with clinicopathological characteristics. Arch Biol Sci. 2020;72(1):31-6. |
Databáze: | OpenAIRE |
Externí odkaz: |